TD Cowen analyst Andrew Sherman raised the firm’s price target on Axon (AXON) to $725 from $700 and keeps a Buy rating on the shares. The firm ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive ...

Septerna was launched by preeminent drug discovery company builders and scientific leaders in the biochemistry, structural biology, and pharmacology of GPCRs. For more information, please visit ...

IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell ...

Warren Buffett has always critiqued airline stocks for being overly capital-intensive, exhibiting low growth, and relying ...

In a report released today, Andrew Kligerman from TD Cowen maintained a Hold rating on Skyward Specialty Insurance Group, Inc. (SKWD – Research ...

Biodesix is a leading diagnostic solutions company with five Medicare-covered tests available for pulmonology patients. The ...

Unilever’s revelation of the departure of Hein Schumacher – before he could celebrate a second summer as CEO – was shrouded ...

Microsoft is one of the largest operators of data centres in the world, and has spent billions of dollars to secure AI ...

Palvella Therapeutics, Inc. (Nasdaq: PVLA) has announced that its management team will deliver a presentation at the TD Cowen ...

Domino’s Pizza (NASDAQ:DPZ – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at TD Cowen in a ...

Nvidia must meet its “normal exceed” of Wall Street expectations to keep its stock price elevated, said an analyst.